NPs Basic Information

Name
Nerolidol
Molecular Formula C15H26O
IUPAC Name*
(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol
SMILES
CC(=CCC/C(=C/CCC(C)(C=C)O)/C)C
InChI
InChI=1S/C15H26O/c1-6-15(5,16)12-8-11-14(4)10-7-9-13(2)3/h6,9,11,16H,1,7-8,10,12H2,2-5H3/b14-11+
InChIKey
FQTLCLSUCSAZDY-SDNWHVSQSA-N
Synonyms
NEROLIDOL; 7212-44-4; trans-Nerolidol; 40716-66-3; 3,7,11-Trimethyldodeca-1,6,10-trien-3-ol; (6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; (E)-3,7,11-Trimethyldodeca-1,6,10-trien-3-ol; 3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol; Nerolidol trans-form; FCI 119b; Peruviol; (+)-Nerolidol; (6E)-nerolidol; 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (6E)-; 3-Hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene; (E)-nerolidol; Nerolidol (natural); FG5V0N8P2H; (3s)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-; NCGC00095837-01; (.+/-.)-Nerolidol; Melaleucol; 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (E)-; Humbertiol; Nerolidol (E); Methylvinylhomogeranyl carbinol; FEMA No. 2772; 3,7,11-Trimethyl-1,6,10-dodecatriene-3-ol; EINECS 230-597-5; UNII-FG5V0N8P2H; EPA Pesticide Chemical Code 128910; BRN 1724135; UNII-QR6IP857S6; AI3-10519; CCRIS 7678; .beta.-Nerolidol; .alpha.-Nerolidol; EINECS 255-053-4; Spectrum5_000460; (+/-)-trans-Nerolidol; .+/-.-trans-Nerolidol; NEROLIDOL, TRANS-; EC 230-597-5; DSSTox_CID_20783; DSSTox_RID_79598; DSSTox_GSID_40783; (6E)-(+/-)-nerolidol; BSPBio_002958; 3-01-00-02042 (Beilstein Handbook Reference); CHEMBL25424; SCHEMBL114136; SPECTRUM1502251; CHEBI:7524; QR6IP857S6; DTXSID2040783; FEMA 2772; CHEBI:141283; NEROLIDOL TRANS-FORM [MI]; HY-N1944; Tox21_111527; trans-Nerolidol, analytical standard; BBL018508; CCG-38883; s5345; STL193540; AKOS015902890; AKOS025310880; SDCCGMLS-0066709.P001; NEROLIDOL, (6E)-(+/-)-; NCGC00095837-02; NCGC00095837-03; 35944-21-9; AS-16074; AS-75500; CAS-40716-66-3; CS-0018255; N0454; A917868; Q415421; SR-05000002467; Q-201460; SR-05000002467-1; W-110939; (6E)-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol; trans-3,7,11-trimethyl-dodeca-1,6,10-trien-3-ol; trans-Nerolidol, primary pharmaceutical reference standard; (E)-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol, trans-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol
CAS 40716-66-3
PubChem CID 5284507
ChEMBL ID CHEMBL25424
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Sesquiterpenoids
          • Direct Parent: Sesquiterpenoids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 222.37 ALogp: 4.6
HBD: 1 HBA: 1
Rotatable Bonds: 7 Lipinski's rule of five: Accepted
Polar Surface Area: 20.2 Aromatic Rings: 0
Heavy Atoms: 16 QED Weighted: 0.606

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.517 MDCK Permeability: 0.00002220
Pgp-inhibitor: 0.659 Pgp-substrate: 0.003
Human Intestinal Absorption (HIA): 0.007 20% Bioavailability (F20%): 0.16
30% Bioavailability (F30%): 0.01

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.363 Plasma Protein Binding (PPB): 97.37%
Volume Distribution (VD): 1.667 Fu: 6.56%

ADMET: Metabolism

CYP1A2-inhibitor: 0.269 CYP1A2-substrate: 0.222
CYP2C19-inhibitor: 0.542 CYP2C19-substrate: 0.848
CYP2C9-inhibitor: 0.237 CYP2C9-substrate: 0.913
CYP2D6-inhibitor: 0.363 CYP2D6-substrate: 0.09
CYP3A4-inhibitor: 0.729 CYP3A4-substrate: 0.232

ADMET: Excretion

Clearance (CL): 8.731 Half-life (T1/2): 0.273

ADMET: Toxicity

hERG Blockers: 0.015 Human Hepatotoxicity (H-HT): 0.317
Drug-inuced Liver Injury (DILI): 0.012 AMES Toxicity: 0.002
Rat Oral Acute Toxicity: 0.004 Maximum Recommended Daily Dose: 0.039
Skin Sensitization: 0.935 Carcinogencity: 0.045
Eye Corrosion: 0.438 Eye Irritation: 0.974
Respiratory Toxicity: 0.018
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000314 1.000 D05XQE 0.417
ENC001716 0.750 D09XWD 0.372
ENC001467 0.549 D03VFL 0.333
ENC001096 0.545 D0M1PQ 0.283
ENC002570 0.544 D06BLQ 0.175
ENC001664 0.519 D05PLH 0.171
ENC001717 0.518 D0X7XG 0.165
ENC001649 0.481 D0S7WX 0.165
ENC001718 0.478 D0Z5BC 0.164
ENC000287 0.472 D09ANG 0.160
*Note: the compound similarity was calculated by RDKIT.